Berman S, Roark R
Children's Hospital, Denver, CO 80218.
Pediatr Infect Dis J. 1993 Jan;12(1):20-4. doi: 10.1097/00006454-199301000-00006.
Factors affecting outcome were analyzed from 3 antibiotic clinical trials that had identical case definition and outcome criteria. Overall 102 subjects with acute otitis media had an initial tympanocentesis, were enrolled in one of the clinical trials, were randomized to receive 10 days of oral treatment and had a posttherapy visit. The antibiotics used were cefixime (38), cefaclor (25), loracarbef (14), amoxicillin plus clavulanate (16) or amoxicillin (9). Fifty-five of the 102 (54%) study subjects were classified as cured or improved at the 21- to 28-day posttherapy visit. Factors analyzed in relation to outcome included antibiotic administered, isolation of a pathogen from the middle ear aspirate, study subject age and sex, history of recurrent otitis media, unilateral vs. bilateral involvement, season of enrollment and history of antibiotic administration in the month before enrollment. Univariate analysis identified the following four factors associated with higher posttherapy visit failure rates: a history of recurrent otitis media; enrollment during winter respiratory season (December through March); a history of being treated with an antibiotic during the month before enrollment; and administration of cefaclor compared with other antibiotics. However, only a history of recurrent otitis media and enrollment during the winter respiratory season met the 0.05 significance level for entry into a model derived from logistic regression to assess interactions among factors. Clinical guidelines for the management of otitis media should take into consideration that children with a prior history or recurrent otitis media and infection during the winter season more often fail to respond to antibiotic treatment and have a higher risk of developing a persistent middle ear effusion.
从3项具有相同病例定义和结局标准的抗生素临床试验中分析了影响结局的因素。共有102例急性中耳炎患者接受了初始鼓膜穿刺术,参加了其中一项临床试验,被随机分配接受10天的口服治疗,并在治疗后进行了随访。使用的抗生素为头孢克肟(38例)、头孢克洛(25例)、氯碳头孢(14例)、阿莫西林加克拉维酸(16例)或阿莫西林(9例)。102例研究对象中有55例(54%)在治疗后21至28天的随访中被分类为治愈或改善。与结局相关分析的因素包括使用的抗生素、从中耳吸出物中分离出病原体、研究对象的年龄和性别、复发性中耳炎病史、单侧与双侧受累、入组季节以及入组前一个月的抗生素使用史。单因素分析确定了以下四个与治疗后随访失败率较高相关的因素:复发性中耳炎病史;冬季呼吸道疾病高发季节(12月至3月)入组;入组前一个月有抗生素治疗史;与其他抗生素相比使用头孢克洛。然而,只有复发性中耳炎病史和冬季呼吸道疾病高发季节入组在纳入逻辑回归模型以评估因素间相互作用时达到了0.05的显著性水平。中耳炎管理的临床指南应考虑到有复发性中耳炎病史以及在冬季感染的儿童对抗生素治疗往往反应不佳,且发生持续性中耳积液的风险更高。